On November 8, 2017, the Federal Trade Commission (FTC) conducted a public workshop entitled, “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics.” The second session evaluated intermediaries in the pharmaceutical supply chain, focusing on pharmacy benefit managers (PBMs) and group purchasing organizations (GPOs).  Food Marketing Institute (FMI), on behalf of the food retail industry, seeks to provide input regarding the impact of current intermediaries in the pharmaceutical supply chain on retail pharmacies,  and potential solutions to enhance transparency and competition in delivering prescription drugs and medicines to retail pharmacies.